1-3 of 3
Hongxing Liu, Sr.
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Naturally Selected CD7-Targeted Chimeric Antigen Receptor (CAR)-T Cell Therapy for Refractory/Relapsed Acute Myeloid Leukemia: Phase I Clinical Trial

Xian Zhang, Junfang Yang, Jingjing Li, Liyuan Qiu, Hongxing Liu, Sr., Min Xiong, Jianqiang Li, Peihua Lu
Journal: Blood
Blood (2023) 142 (Supplement 1): 218.
https://doi.org/10.1182/blood-2023-179086
Published: 2023
Journal Articles

A Parallel Comparison of the Safety and Efficacy of Allogeneic Hematopoietic Stem Cell Transplantation for Refractory and Relapsed T-ALL/Lbl Patients Who Achieved Complete Remission with CD7 CAR-T Versus Patients Who Achieved First Complete Remission with Chemotherapy before Transplantation

Xingyu Cao, Jianping Zhang, Yue Lu, Yanli Zhao, Deyan Liu, Min Xiong, Ruijuan Sun, Zhijie Wei, Jiarui Zhou, Xian Zhang, Junfang Yang, Hongxing Liu, Sr., Peihua Lu
Journal: Blood
Blood (2023) 142 (Supplement 1): 3611.
https://doi.org/10.1182/blood-2023-185696
Published: 2023
Journal Articles

Clinical Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation Using Busulfan/Cyclophosphamide and Melphalan or Thiotepa As Conditioning Regimen in 37 Patients with Acute Megakaryoblastic Leukemia

Fei Pan, Hongxing Liu, Sr., Guanlan Yue, Kang Gao, Kun Wang, Huili Zhu, Yujie Wang, Zheren Wang, Zhijie Wei
Journal: Blood
Blood (2023) 142 (Supplement 1): 6964.
https://doi.org/10.1182/blood-2023-181494
Published: 2023